Contribution of 2nd Generation TKI in 1st or 2nd Line

Date 28 October 2016
Event ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016
Session Session 1 The already long journey of EGFR TKI
Topics Anti-Cancer Agents & Biologic Therapy
Presenter S. Popat, UK